Phase I Trial of Vorinostat (MK-0683, SAHA) in Combination With Decitabine in Patients With AML or MDS (MK-0683-055 EXT1)

Clinical trial NCT00479232 · COMPLETED

Trial details

NCT number: NCT00479232
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Myelocytic, Acute Myelodysplastic Syndromes Myelodysplastic Syndromes

Start date: 2007-06-01
Primary completion: 2010-04-01
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.